Literature DB >> 10835502

Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect.

K Saito1, N Mikuniya, K Aizawa.   

Abstract

The effect of photodynamic therapy (PDT) on the vascular system has a significant role in tumor tissue destruction. We investigated the contribution of vascular damage to the antitumor effects of PDT and analyzed the quantitative vascular changes after PDT. Fibrosarcoma-bearing BALB / c male mice were injected with mono-L-aspartyl chlorin e6 (NPe6) at a dose of 0.25, 5 or 15 mg / kg, and photoradiation was performed with a diode laser 10 min, 2 h or 24 h after injection, respectively. Ten minutes after injection of 0. 25 mg / kg, NPe6 was found to be present only in plasma, while at 2 h after injection of 5 mg / kg it was present in both plasma and tumor, and 24 h after injection of 15 mg / kg it was present only in the tumor. The antitumor effects observed in the 5 mg / kg-2 h and 0. 25 mg / kg-10 min groups were virtually the same, whereas the effect in the 15 mg / kg-24 h group was weaker. The damage to the tumor vasculature and tumor cells in the 15 mg / kg-24 h group occurred later than under the other conditions, and vascular damage in the tumor-surrounding tissue was also less marked even 24 h after PDT. These results suggested that the plasma NPe6 concentration during laser irradiation contributed more than the tumor NPe6 concentration to the antitumor effect, and that the minimal damage to blood vessels around the tumor at the low plasma NPe6 concentration may be one reason for the failure to obtain a marked antitumor effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835502      PMCID: PMC5926381          DOI: 10.1111/j.1349-7006.2000.tb00981.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.

Authors:  A Ferrario; D Kessel; C J Gomer
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

2.  In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.

Authors:  J S Nelson; W G Roberts; M W Berns
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

3.  Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.

Authors:  C J Gomer; A Ferrario
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

4.  The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy.

Authors:  V H Fingar; K A Siegel; T J Wieman; K W Doak
Journal:  Photochem Photobiol       Date:  1993-09       Impact factor: 3.421

5.  Skin photosensitivity and photodestruction of several potential photodynamic sensitizers.

Authors:  W G Roberts; K M Smith; J L McCullough; M W Berns
Journal:  Photochem Photobiol       Date:  1989-04       Impact factor: 3.421

Review 6.  Vascular effects of photodynamic therapy.

Authors:  V H Fingar
Journal:  J Clin Laser Med Surg       Date:  1996-10

7.  Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.

Authors:  K S McMahon; T J Wieman; P H Moore; V H Fingar
Journal:  Cancer Res       Date:  1994-10-15       Impact factor: 12.701

8.  The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.

Authors:  I Sheyhedin; K Aizawa; M Araake; H Kumasaka; T Okunaka; H Kato
Journal:  Photochem Photobiol       Date:  1998-07       Impact factor: 3.421

9.  Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

Authors:  V H Fingar; P K Kik; P S Haydon; P B Cerrito; M Tseng; E Abang; T J Wieman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice.

Authors:  T Katsumi; K Aizawa; T Okunaka; Y Kuroiwa; Y Ii; K Saito; C Konaka; H Kato
Journal:  Jpn J Cancer Res       Date:  1994-11
View more
  4 in total

Review 1.  Photodynamic therapy in head and neck cancer.

Authors:  Merrill A Biel
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapy.

Authors:  Michael Price; Lance Heilbrun; David Kessel
Journal:  Photochem Photobiol       Date:  2013-01-25       Impact factor: 3.421

3.  Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles.

Authors:  Sharmin Akter; Mizuho Inai; Sachiko Saito; Norihiro Honda; Hisanao Hazama; Tomoyuki Nishikawa; Yasufumi Kaneda; Kunio Awazu
Journal:  Laser Ther       Date:  2019-12-31

4.  Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma.

Authors:  Shinya Ohashi; Osamu Kikuchi; Mihoko Tsurumaki; Yukie Nakai; Hiroi Kasai; Takahiro Horimatsu; Shin'ichi Miyamoto; Akira Shimizu; Tsutomu Chiba; Manabu Muto
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.